Highlights: HRT after breast cancer and other cancers
- It depends on your cancer.
HRT is generally not recommended for breast cancer survivors but can be discussed after many other cancers. - Vaginal oestrogen is different.
Your breast team may agree to it if moisturisers fail, with extra care on an aromatase inhibitor. - Non-hormonal treatments can help.
CBT and several medicines eased hot flushes in trials. - Early menopause needs care.
Unless you had breast or hormone-sensitive cancer, HRT until about 51, agreed with your oncologist, helps protect your bones and heart.
Quick Answer: It depends on the type of cancer you had
Can you take HRT after breast cancer?
Usually not, but other treatments can help. Menopausal HRT differs from hormone therapy for breast cancer, such as tamoxifen. NICE NG101 says to stop systemic HRT at diagnosis and offer it afterwards only in exceptional cases of severe symptoms, after discussing the risks. In the UK this is off-label for all HRT, and the British Menopause Society (BMS) says any use needs your breast team’s input and must not be combined with an aromatase inhibitor.
All three randomised trials of HRT or tibolone (an HRT-like medicine) after breast cancer stopped early, two because of more recurrences. In HABITS, after a median of 4 years, 39 of 221 women on HRT had breast cancer again, compared with 17 of 221 without it. In LIBERATE, recurrence was 15.2% on tibolone and 10.7% on placebo. The Stockholm trial found no clear overall rise, but more cancers in the other breast.
What the main trials of HRT after breast cancer found
HRT or tibolone
No HRT or placebo
Does your type of breast cancer or treatment change the answer?
Not for systemic HRT, but tamoxifen and aromatase inhibitors change the advice on vaginal oestrogen (see below). Even after receptor-negative cancer, no guideline supports routine systemic HRT, and the BMS notes it may not be risk-free.
If you carry a BRCA variant without breast cancer, NICE NG241 says to offer HRT until about 51 if your ovaries are removed before then.
Is vaginal estrogen safe after breast cancer?
It may be. Vaginal oestrogen comes as tablets, creams or a ring, and very little is absorbed. NICE NG23 suggests:
- Moisturisers at least twice a week, and lubricants for sex (BMS).
- If these do not help, vaginal oestrogen may be considered with your breast team, though its effect on recurrence is unknown and the evidence is sparse.
- After oestrogen receptor-negative cancer it is likely to be safe. If you take tamoxifen, it would reduce any effect on recurrence.
- If you take an aromatase inhibitor, vaginal oestrogen may make it work less well. Experts differ: NICE asks your specialists to plan together, the BMS generally advises against it, and ACOG allows a low dose if you and your oncologist agree. Please do not stop or change any cancer medicine without talking to your oncologist.
Studies of 8,461 Danish and 49,237 UK women were reassuring overall, but the Danish one found more recurrences alongside an aromatase inhibitor.
Can you take HRT after womb, ovarian or cervical cancer?
A gynaecological cancer does not automatically rule out HRT, says UK guidance (BGCS and BMS 2024).
After early womb (endometrial) cancer, a Cochrane review found no sign of significant harm in the only randomised trial (GOG 137), though it closed early.
Cervical, vaginal and vulval cancers are not considered hormone dependent, though after cervical adenocarcinoma the decision is more individual.
HRT after cancer at a glance
| Cancer | HRT tablets, patches or gels | Vaginal oestrogen |
|---|---|---|
| Breast | Generally not recommended Only in exceptional cases of severe symptoms, after discussing the risks | Case by case May be considered with your breast team; extra care on an aromatase inhibitor |
| Womb, low or intermediate risk | Often possible Can be discussed | Often possible Usually safe |
| Womb, higher risk | Case by case Receptor-negative: case by case. Receptor-positive: not recommended | Case by case Case by case |
| Uterine sarcoma | Generally not recommended Avoid | Generally not recommended Avoid |
| Ovarian, high-grade serous | Often possible Not usually ruled out; discuss | Often possible Usually safe |
| Ovarian, low-grade serous | Case by case Stage I: discuss. Later stages: not recommended | Often possible Usually safe; ask your team |
| Ovarian, granulosa cell | Generally not recommended Usually avoided; stage I: specialist advice | Often possible Usually safe |
| Cervical, vaginal, vulval | Often possible Not ruled out | Often possible Usually safe |
| Blood cancers | Often possible Menopause before 40: advised, tailored with your haematologist | Case by case Little evidence |
| Bowel, lung, melanoma, thyroid | Case by case Lung: uncertain. Others: not ruled out; limited evidence | Case by case Little evidence |
Early menopause after chemotherapy, surgery or radiotherapy
Chemotherapy can stop your ovaries working whatever cancer you had, and womb cancer surgery usually brings on menopause if you have not been through it.
If menopause comes before 40 after a cancer that is not hormone sensitive, NICE advises HRT or the combined pill until about 51, agreed with your oncologist. This does not apply after any breast cancer, even a receptor-negative one.
Without hormones, menopause before 40 is linked with weaker bones and, on average, shorter lives, mainly from heart disease (ESHRE 2024; see why oestrogen matters). If you cannot take hormones, please ask what else protects your bones and heart.
Non-hormonal treatments for hot flushes and night sweats
If you cannot take HRT after breast cancer, trials show several other treatments can help (The Menopause Society). Paroxetine and fluoxetine are avoided with tamoxifen as they may weaken it, but please ask your doctor before stopping either. NICE advises against soy (isoflavone) supplements, red clover, black cohosh and vitamin E after breast cancer.
Non-hormonal treatments: what the trials found
Treatment
Placebo or usual care
What is different about menopause care after cancer in Dubai and the rest of the UAE?
In the UAE, menopause often overlaps with breast cancer treatment. Breast cancer is the most common cancer in UAE women (31.4% of their cancers in 2024) and is diagnosed most often at 40 to 49 (UAE cancer registry). Please check your insurance, and ask whether fezolinetant or elinzanetant is available here.
When should you see a specialist?
Please see a menopause specialist if:
- Hot flushes, poor sleep or vaginal symptoms affect your daily life.
- Your periods stopped before 45 after treatment.
- Your treatment may bring on menopause. NICE advises talking to a menopause expert before and after treatment.
What to bring: your cancer type, stage and receptor status, current medicines, your oncologist’s latest letter and our questions to ask your doctor about HRT.
How Menovivre supports women after cancer
Dr Nirusha Kumaran leads the menopause clinic at Menovivre, where we offer menopause care after breast cancer or another cancer in Dubai. Options include non-hormonal medicines, local treatments for vaginal and urinary problems chosen to suit your medical history, and a bone health assessment such as our Postmenopausal Health Check. After breast cancer, please agree each treatment with your oncologist or breast team.
Frequently Asked Questions
Q1: Can I take HRT after breast cancer?
Q2. Is vaginal estrogen safe after breast cancer?
Q3. What helps hot flushes after cancer?
